Please try another search
Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It also is developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It is a patented extracorporeal treatment that is applicable to many hard-to-cure blood-borne and neurologic diseases, including Covid-19, other viruses and cancer. The Company’s wholly owned subsidiary is Alaric Corporation.
Name | Age | Since | Title |
---|---|---|---|
Carl Eller | - | - | Member of the Scientific Advisory Board |
Edson Luis de Brito | - | - | Member of the Scientific Advisory Board |
Heidi H. Carl | 51 | - | Director & Accounting Director |
Patricio F. Reyes | 75 | - | Chief Mechanical Officer & Member of the Scientific Advisory Board |
William A. Hartman | 80 | - | President, CEO & Chairman |
John S. Borza | 68 | - | COO & Director |
Mitchell S. Felder | 68 | 2021 | CTO & Member of the Scientific Advisory Board |
David Wilson | - | - | Member of the Scientific Advisory Board |
Abdon Luiz Goncalves Nanhay | - | - | Member of the Scientific Advisory Board |
Ned Kronfol | - | - | Member of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review